GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...

A network meta-analysis reveals age-dependent variations in efficacy of popular diabetes drugs, with SGLT2 inhibitors showing ...

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional ...

Bariatric surgery is safe and induces substantial weight loss that reduces the need for diabetes medications, a Monash ...

The study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

Discover how modern diabetes medications offer cardiovascular benefits, transforming diabetes care and improving outcomes worldwide.

A new and increasingly widely used diabetes medication may have additional health benefits for older adults, according to new ...

Groundbreaking research reveals how common diabetes medications might offer unprecedented protection against heart attacks ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

A new study finds SGLT2 inhibitors like Jardiance and GLP-1 drugs like Ozempic provide different benefits depending on the ...